Publications
106
Citations
2,485
Est. group size
~2
Recurring co-author estimate
Active years
57
Publishing since 1969
Typically publishes in teams of ~7 · 14% small-team papers (≤3 authors) · across 10 venues
- Su1643: MULTIDISCIPLINARY ALCOHOL-ASSOCIATED LIVER DISEASE CARE: ASSESSING CHANGES IN DEPRESSION AND ANXIETY SCORES WITH SHIFTING ALCOHOL USE
Gastroenterology · 2025
- The Role of Depression in Pain Coping and Opioid Use in Traumatic Injury Patients
2025
- Patient-Level Insights into Maintenance of Good Inhaler Technique Over Time With Use of a Digihaler System
2024
- 482 Burnout, satisfaction, and retention of advanced practice provider workforce in CF
Journal of Cystic Fibrosis · 2024
- CONNECT3: design and rationale for a study of the BF Digihaler System in adult patients with asthma
2023
- M15 Quantification of clinical deterioration of asthma based on threshold for SABA use in two studies of the digihaler system
2023
- Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1)
The Journal of Allergy and Clinical Immunology In Practice · 2022
- Assessment of Real-World Escalation to Biologics in US Patients With Asthma
The Journal of Allergy and Clinical Immunology In Practice · 2022
- Suboptimal Adherence to Controller Medication is Widespread Among Asthma Patients Escalated to Biologics: an Analysis of US Claims Data
Journal of Allergy and Clinical Immunology · 2022
- Pathways of Escalation to Asthma Biologics in Real-world Clinical Practice: an Analysis of US Claims Data
Journal of Allergy and Clinical Immunology · 2022
- Effectiveness of a reliever-based Digital System on asthma control
2022
- Digital Health Technology in Asthma: A Comprehensive Scoping Review
The Journal of Allergy and Clinical Immunology In Practice · 2021
- Assessing Asthma Control By Frequency Of High Systemic Corticosteroid And/or SABA Prescriptions In US Administrative Claims Data
Journal of Allergy and Clinical Immunology · 2021
- Short-Acting Beta-Agonist Bursts and Overuse in Patients with Poorly Controlled Asthma, as Recorded by a Digital Inhaler
2021
- Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes
British Journal of Haematology · 2020
- The Journal of Allergy and Clinical Immunology In Practice×4
- Journal of Allergy and Clinical Immunology×3
- CHEST Journal×2
- Journal of Asthma and Allergy×1
- JAMA×1
- Njira Lugogo
Medicine · University of Michigan
- Alan P. Baptist
Medicine · University of Michigan
- Anne M. Fitzpatrick
Medicine · The Ohio State University
- Arjun Mohan
Medicine · University of Michigan
- Lisa Ulrich
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile